PURETECH VENTURES has a total of 19 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2008. It filed its patents most often in EPO (European Patent Office), Japan and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, medical technology and organic fine chemistry are FORTUNE APEX DEV LTD, NEOTHETICS INC and GAO GE.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 3 | |
#2 | Japan | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | Australia | 2 | |
#5 | Brazil | 2 | |
#6 | Canada | 2 | |
#7 | Israel | 2 | |
#8 | United States | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Specific use of cosmetics | |
#4 | Diagnosis and surgery | |
#5 | Syringes |
# | Name | Total Patents |
---|---|---|
#1 | Steinberg David | 11 |
#2 | Zohar Daphne | 11 |
#3 | Pojasek Kevin | 6 |
#4 | Behr Jonathan | 5 |
#5 | Olle Bernat | 5 |
#6 | Andrew C Miller | 3 |
#7 | Miller Andrew C | 3 |
#8 | Philip E Murray Iii | 3 |
#9 | Elenko Eric | 3 |
#10 | Eric Elenko | 3 |
Publication | Filing date | Title |
---|---|---|
US2011020423A1 | Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation | |
WO2009061349A1 | Methods, kits, and compositions for administering pharmaceutical compounds | |
WO2008143928A1 | Methods and compositions for treating skin conditions |